AlphAIAlphAI — Financial news for AI agents
finance.yahoo.comOCT 213 min read$ISRG

What Intuitive Surgical (ISRG) Said on Its Q3 Earnings Call

Intuitive Surgical (ISRG) reported Q3 earnings, highlighting 65% of global da Vinci placements were for its 5 and SP systems. The company installed 18 systems in U.S. ambulatory surgery centers, including 15 XiR systems. ISRG placed 56 Ion systems, up from 50 a year earlier. Non-GAAP operating margin was 42% (41% excluding a one-time tariff refund). GAAP net income was $523M, down from $704M a year earlier.

Original reporting
finance.yahoo.com
Published Oct 21, 2026, 12:02 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 21, 2026, 12:09 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
What Intuitive Surgical (ISRG) Said on Its Q3 Earnings Call — source image
Source · finance.yahoo.com
Decision brief

The 30-second read

$ISRGNeutralMed
01

Why it matters

The earnings release provides fresh guidance and operational updates that materially affect valuation.

02

Market read

The earnings and strategic updates are likely to move ISRG and related medical‑device stocks in the short term.

03

What to watch

The upcoming FDA clearance for extended‑use instruments and the Penang manufacturing facility could unlock longer‑term growth not fully priced in.

Relevance 8/10Novelty 8/10Timing: post‑earnings release

Background

Intuitive Surgical reported Q3 results, highlighted system placements, a $450 M litigation settlement, and announced pricing actions to broaden benign‑procedure adoption.

Company-level read

Ticker impact

$ISRGNeutralHigh confidence
Context

Q3 earnings disclosed revenue, margin, settlement, pricing changes and 2026 guidance – first public report of these figures.

Expected impact

mixed pressure as investors weigh lower guidance and pricing cuts against strong cash flow and share repurchases

Evidence & confidence

The settlement and pricing actions introduce near‑term margin headwinds, but robust cash generation and buybacks provide support.

Market effects

Sector

Robotic surgery and medical‑device sector may see valuation adjustments as pricing pressure spreads.

Regional

U.S. healthcare stocks could experience modest volatility following the pricing announcement.

Global

International markets with Intuitive exposure (e.g., Korea) may see short‑term price moves.

Counterpoint

What could challenge this read

If pricing cuts accelerate adoption faster than expected, the stock could outperform despite near‑term margin compression.

Key entities

  • Company
    Intuitive Surgical

    Developer of da Vinci surgical systems.

  • Executive
    Jamie Samath

    Chief Financial Officer who discussed pricing actions and settlement.

Read at source← All news

StoryIntuitive Surgical posts Q3 2026 earnings beat, cites $450 M antitrust settlement and narrows procedure growth outlook

Also covered by

4 outlets

Related articles

OCT 20
$ISRGMedAI 8/10

Intuitive Surgical, Inc (ISRG) Q3 2026 Earnings Call Transcript

Intuitive Surgical (ISRG) reported Q3 2026 earnings, highlighting 15% total procedure growth, with 14% in da Vinci and 31% in Ion procedures. U.S. da Vinci growth was 10%, while international growth was 20%. The company installed over 13,200 da Vinci and Ion systems worldwide. Revenue growth was driven by strong demand for da Vinci 5 and SP platforms, with 28% increase in system placements. The company also announced plans for a new manufacturing facility in Malaysia.

news.alphastreet.com3 min